Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo

被引:60
作者
Giustizieri, ML
Albanesi, C
Scarponi, C
De Pita, O
Girolomoni, G
机构
[1] Ist Ric & Cura & Carattere Sci, Ist Dermopat Immacolata, Immunol Lab, I-00167 Rome, Italy
[2] Ist Ric & Cura & Carattere Sci, Ist Dermopat Immacolata, Lab Allergy & Clin Immunol, Rome, Italy
[3] Ist Ric & Cura & Carattere Sci, Ist Dermopat Immacolata, Div Dermatol 2, Rome, Italy
关键词
D O I
10.1016/S0002-9440(10)64416-1
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Nitric oxide (NO) is involved in the modulation of inflammatory responses. In psoriatic skin, NO is highly produced by epidermal keratinocytes in response to interferon-gamma and tumor necrosis factor-alpha. In this study, we investigated whether the No donors, S-nitrosoglutathione (GS-NO) and NOR-1, could regulate chemokine production by human keratinocytes activated with interferon-gamma and tumor necrosis factor-a. in addition, we studied the effects of the topical application of a GS-NO ointment on chemokine expression in lesional psoriatic skin. NO donors diminished in a dose-dependent manner and at both mRNA and protein levels the IP-10, RANTES, and MCP-1 expression in keratinocytes cultured from healthy patients and psoriatic patients. In contrast, constitutive and induced interleukin-8 production was unchanged. GS-NO-treated psoriatic skin showed reduction of IP-10, RANTES, and MCP-1, but not interleukin-8 expression by keratinocytes. Moreover, the number of CD14(+) and CD3(+) cells infiltrating the epidermis and papillary dermis diminished significantly. NO donors also down-regulated ICAM-1 protein expression without affecting mRNA accumulation in vitro, and suppressed keratinocyte ICAM-1 in vivo. Finally, NO donors inhibited nuclear factor-kappaB and STAT-1, but not AP-1 activities in transiently transfected keratinocytes. These results define No donors as negative regulators of chemokine production by keratinocytes.
引用
收藏
页码:1409 / 1418
页数:10
相关论文
共 41 条
[1]
IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines [J].
Albanesi, C ;
Scarponi, C ;
Sebastiani, S ;
Cavani, A ;
Federici, M ;
De Pità, O ;
Puddu, P ;
Girolomoni, G .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1395-1402
[2]
Albanesi C, 1999, J IMMUNOL, V162, P494
[3]
Albanesi C, 2001, J LEUKOCYTE BIOL, V70, P617
[4]
Novel immunotherapies for psoriasis [J].
Asadullah, K ;
Volk, HD ;
Sterry, W .
TRENDS IN IMMUNOLOGY, 2002, 23 (01) :47-53
[5]
MARKED SYNERGISM BETWEEN TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA IN REGULATION OF KERATINOCYTE-DERIVED ADHESION MOLECULES AND CHEMOTACTIC FACTORS [J].
BARKER, JNWN ;
SARMA, V ;
MITRA, RS ;
DIXIT, VM ;
NICKOLOFF, BJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :605-608
[6]
Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[7]
The pathogenesis of psoriasis: Immunological facts and speculations [J].
Bos, JD ;
De Rie, MA .
IMMUNOLOGY TODAY, 1999, 20 (01) :40-46
[8]
Stromal cell-derived factor 1α-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways [J].
Cherla, RP ;
Ganju, RK .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3067-3074
[9]
Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors [J].
Dieu-Nosjean, MC ;
Massacrier, C ;
Homey, B ;
Vanbervliet, B ;
Pin, JJ ;
Vicari, A ;
Lebecque, S ;
Dezutter-Dambuyant, C ;
Schmitt, D ;
Zlotnik, A ;
Caux, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :705-717
[10]
Transcriptional regulation in the immune system: all roads lead to AP-1 [J].
Foletta, VC ;
Segal, DH ;
Cohen, DR .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (02) :139-152